rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study
Clinical trial NCT03829449 · TERMINATED
Trial details
- NCT number
- NCT03829449
- Sponsor
- AKARI Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2020-08-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.